|1.||Kazekawa, K: 3 articles (12/2001 - 07/2000)|
|2.||Sefton, M V: 2 articles (04/2000 - 03/2000)|
|3.||Babensee, J E: 2 articles (04/2000 - 03/2000)|
|4.||Ma, Lih: 1 article (07/2005)|
|5.||Huang, Zei-Lun: 1 article (07/2005)|
|6.||Garway-Heath, David F: 1 article (12/2003)|
|7.||Steuhl, Klaus-Peter: 1 article (12/2003)|
|8.||De Cilla, Stefano: 1 article (12/2003)|
|9.||Selbach, J Michael: 1 article (12/2003)|
|10.||Kremmer, Stephan: 1 article (12/2003)|
|1.||Hepatocellular Carcinoma (Hepatoma)
04/01/2000 - "Viability of HEMA-MMA microencapsulated model hepatoma cells in rats and the host response."
10/01/1993 - "We conclude that HEMA-MMA capsules, in the presence of an attachment substrate, provide a suitable environment for the growth and expression of differentiated functions of encapsulated hepatoma cells."
11/01/1992 - "Hepatoma cells (HepG2), an anchorage-dependent cell line, were microencapsulated in a HEMA-MMA polyacrylate membrane to which the cells do not adhere. "
03/01/2000 - "Rat or human hepatoma cells in HEMA-MMA microcapsules lost viability within a week after implantation into an omental pouch in Wistar rats. "
11/01/1992 - "Morphological assessment of hepatoma cells (HepG2) microencapsulated in a HEMA-MMA copolymer with and without Matrigel."
06/01/1999 - "The influence of cataract surgery in phacotechnique with intraocular lens implantation (31 PMMA-IOLs, Pharmacia/Upjohn, model 811 B, and 25 HEMA/MMA-IOLs, Technomed, Memory Lens) on SLT and SLP was evaluated before and 3 to 4 weeks after cataract surgery in 56 eyes of otherwise healthy patients. "
12/01/2003 - "The influence of phacoemulsification cataract surgery with intraocular lens implantation (56 polymethylmethacrylate [PMMA; 31 Pharmacia/Upjohn 811 B and 25 Domilens Flex 60]; 25 hydroxyethylmethacrylate/methylmethacrylate (HEMA/MMA) [Technomed, Memory Lens]; 32 silicone [Allergan Si40]; 25 acrylic [Storz Hydroview]) on SLP and SLT measurements was evaluated preoperatively and 3 to 4 weeks postoperatively in 138 eyes of otherwise healthy patients. "
|3.||Arteriovenous Malformations (Arteriovenous Malformation)
11/30/1997 - "Characteristics of a New Liquid Material for Arteriovenous Malformations (HEMA-MMA)."
12/22/2001 - "We have recently developed a non-adhesive liquid embolic agent, hydroxyethylmethacrylate methylmethacrylate copolymer (HEMA-MMA), and used it for arteriovenous malformations (AVMs) in the central nervous system. "
|4.||Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula)
|5.||Alveolar Bone Loss
|1.||hydroxyethyl methacrylate (HEMA)
|3.||Polymethyl Methacrylate (Sol)
|1.||Intraocular Lens Implantation